Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study
Ying Wang,1 Xiaoxiao Zhao,1 Peng Zhou,1 Chen Liu,1 Zhaoxue Sheng,1,2 Jiannan Li,1 Jinying Zhou,1 Runzhen Chen,1 Yi Chen,1 Li Song,1 Hanjun Zhao1 *, Hongbing Yan3 𪇞partment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College &a...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b73dafe2076744979bedddb9448aad60 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b73dafe2076744979bedddb9448aad60 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b73dafe2076744979bedddb9448aad602021-12-02T16:39:04ZPlasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study1178-7031https://doaj.org/article/b73dafe2076744979bedddb9448aad602021-09-01T00:00:00Zhttps://www.dovepress.com/plasma-pentraxin-3-combined-with-plaque-characteristics-predict-cardio-peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Ying Wang,1 Xiaoxiao Zhao,1 Peng Zhou,1 Chen Liu,1 Zhaoxue Sheng,1,2 Jiannan Li,1 Jinying Zhou,1 Runzhen Chen,1 Yi Chen,1 Li Song,1 Hanjun Zhao1 *, Hongbing Yan3 𪇞partment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2Department of Cardiology, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 3Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, People’s Republic of China* These authors contributed equally to this workCorrespondence: Hongbing YanDepartment of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, No. 12, Langshan Road, Xili Street, Nanshan District, Shenzhen, 518000, People’s Republic of ChinaTel +86-10-88322285Email hbyanfuwai2018@163.comHanjun ZhaoDepartment of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, No. 167 Beilishi Road, Xicheng District, Beijing, 100037, People’s Republic of ChinaTel +86-15210020808Email 15210020808@163.comBackground: Culprit‑plaque morphology [plaque rupture (PR) and plaque erosion (PE) identified by optical coherence tomography (OCT)] and biomarker of vascular inflammation, pentraxin-3 (PTX3), have been reported to influence clinical outcomes in coronary diseases. We aimed to investigate the prognostic implication of culprit-plaque morphology and plasma PTX3 for major adverse cardiovascular events (MACE) in patients with ST-segment elevation myocardial infarction (STEMI).Methods: A total of 236 patients were enrolled and divided into four groups: PE/low-PTX3 (n = 57), PE/high-PTX3 (n = 47), PR/low-PTX3 (n = 78) and PR/high-PTX3 (n = 54). MACE was defined as the composite of all-cause death, recurrence of myocardial infarction, stroke and unplanned revascularization of any coronary artery.Results: During the follow-up of 1.9 years, a total of 40 (16.9%) MACE were observed: 5.3% (3 patients) among patients with PE/low-PTX3, 21.3% (10 patients) among patients with PE/high-PTX3, 17.9% (14 patients) among patients with PR/low-PTX3 and 24.1% (13 patients) among patients with PR/high-PTX3 (Log rank P = 0.013). In fully adjusted analyses, patients with high-PTX3 were associated with higher MACE risk (HR: 2.40, 95% CI: 1.26– 4.57, P = 0.008). Patients with PR/high-PTX3 (HR: 5.63, 95% CI: 1.57– 20.16, P = 0.008) and PE/high-PTX3 (HR: 5.44, 95% CI: 1.46– 20.29, P = 0.012) presented higher MACE risk than those with PE/low-PTX3. Adding plasma PTX3 levels and PR to the risk prediction model increased the area under curves to 76.1% (95% CI: 67.6– 84.5%) and the NRI (28.1%, 95% CI: 0.3– 48.3%, P=0.040) and IDI (2.4%, 95% CI: 0.1– 12.9%, P = 0.040).Conclusion: Patients with PR/high-PTX3 and PE/high-PTX3 presented a poorer prognosis than those with PE/low-PTX3. Combining the culprit-plaque morphology with PTX3 enhanced the predictive ability for MACE and contributed to better identification of high-risk patients.Trial Registration Number: This study is registered at clinical trials.gov as NCT03593928.Keywords: pentraxin-3, plaque rupture, optical coherence tomography, cardiovascular risk, ST-segment elevation myocardial infarctionWang YZhao XZhou PLiu CSheng ZLi JZhou JChen RChen YSong LZhao HYan HDove Medical Pressarticlepentraxin-3plaque ruptureoptical coherence tomographycardiovascular riskst-segment elevation myocardial infarctionPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 4409-4419 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
pentraxin-3 plaque rupture optical coherence tomography cardiovascular risk st-segment elevation myocardial infarction Pathology RB1-214 Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
pentraxin-3 plaque rupture optical coherence tomography cardiovascular risk st-segment elevation myocardial infarction Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Wang Y Zhao X Zhou P Liu C Sheng Z Li J Zhou J Chen R Chen Y Song L Zhao H Yan H Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study |
| description |
Ying Wang,1 Xiaoxiao Zhao,1 Peng Zhou,1 Chen Liu,1 Zhaoxue Sheng,1,2 Jiannan Li,1 Jinying Zhou,1 Runzhen Chen,1 Yi Chen,1 Li Song,1 Hanjun Zhao1 *, Hongbing Yan3 𪇞partment of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2Department of Cardiology, China-Japan Friendship Hospital, Beijing, People’s Republic of China; 3Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, People’s Republic of China* These authors contributed equally to this workCorrespondence: Hongbing YanDepartment of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, No. 12, Langshan Road, Xili Street, Nanshan District, Shenzhen, 518000, People’s Republic of ChinaTel +86-10-88322285Email hbyanfuwai2018@163.comHanjun ZhaoDepartment of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, No. 167 Beilishi Road, Xicheng District, Beijing, 100037, People’s Republic of ChinaTel +86-15210020808Email 15210020808@163.comBackground: Culprit‑plaque morphology [plaque rupture (PR) and plaque erosion (PE) identified by optical coherence tomography (OCT)] and biomarker of vascular inflammation, pentraxin-3 (PTX3), have been reported to influence clinical outcomes in coronary diseases. We aimed to investigate the prognostic implication of culprit-plaque morphology and plasma PTX3 for major adverse cardiovascular events (MACE) in patients with ST-segment elevation myocardial infarction (STEMI).Methods: A total of 236 patients were enrolled and divided into four groups: PE/low-PTX3 (n = 57), PE/high-PTX3 (n = 47), PR/low-PTX3 (n = 78) and PR/high-PTX3 (n = 54). MACE was defined as the composite of all-cause death, recurrence of myocardial infarction, stroke and unplanned revascularization of any coronary artery.Results: During the follow-up of 1.9 years, a total of 40 (16.9%) MACE were observed: 5.3% (3 patients) among patients with PE/low-PTX3, 21.3% (10 patients) among patients with PE/high-PTX3, 17.9% (14 patients) among patients with PR/low-PTX3 and 24.1% (13 patients) among patients with PR/high-PTX3 (Log rank P = 0.013). In fully adjusted analyses, patients with high-PTX3 were associated with higher MACE risk (HR: 2.40, 95% CI: 1.26– 4.57, P = 0.008). Patients with PR/high-PTX3 (HR: 5.63, 95% CI: 1.57– 20.16, P = 0.008) and PE/high-PTX3 (HR: 5.44, 95% CI: 1.46– 20.29, P = 0.012) presented higher MACE risk than those with PE/low-PTX3. Adding plasma PTX3 levels and PR to the risk prediction model increased the area under curves to 76.1% (95% CI: 67.6– 84.5%) and the NRI (28.1%, 95% CI: 0.3– 48.3%, P=0.040) and IDI (2.4%, 95% CI: 0.1– 12.9%, P = 0.040).Conclusion: Patients with PR/high-PTX3 and PE/high-PTX3 presented a poorer prognosis than those with PE/low-PTX3. Combining the culprit-plaque morphology with PTX3 enhanced the predictive ability for MACE and contributed to better identification of high-risk patients.Trial Registration Number: This study is registered at clinical trials.gov as NCT03593928.Keywords: pentraxin-3, plaque rupture, optical coherence tomography, cardiovascular risk, ST-segment elevation myocardial infarction |
| format |
article |
| author |
Wang Y Zhao X Zhou P Liu C Sheng Z Li J Zhou J Chen R Chen Y Song L Zhao H Yan H |
| author_facet |
Wang Y Zhao X Zhou P Liu C Sheng Z Li J Zhou J Chen R Chen Y Song L Zhao H Yan H |
| author_sort |
Wang Y |
| title |
Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study |
| title_short |
Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study |
| title_full |
Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study |
| title_fullStr |
Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study |
| title_full_unstemmed |
Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study |
| title_sort |
plasma pentraxin-3 combined with plaque characteristics predict cardiovascular risk in st-segment elevated myocardial infarction: an optical coherence tomography study |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/b73dafe2076744979bedddb9448aad60 |
| work_keys_str_mv |
AT wangy plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT zhaox plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT zhoup plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT liuc plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT shengz plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT lij plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT zhouj plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT chenr plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT cheny plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT songl plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT zhaoh plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy AT yanh plasmapentraxin3combinedwithplaquecharacteristicspredictcardiovascularriskinstsegmentelevatedmyocardialinfarctionanopticalcoherencetomographystudy |
| _version_ |
1718383595779784704 |